|
|
|
|
Дата |
|---|
| 05.10.2026 |
| 04.10.2026 |
| 01.10.2026 |
| 30.09.2026 |
| 29.09.2026 |
| 28.09.2026 |
| 27.09.2026 |
| 24.09.2026 |
| 23.09.2026 |
| 22.09.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
117.25
|
113.00
|
118.00
|
113.99
|
|
|
40 169 074.93
|
1 632.00
|
|
|
|
115.80
|
115.51
|
119.20
|
117.25
|
|
|
71 269 012.52
|
2 392.00
|
|
|
|
113.90
|
113.50
|
117.35
|
115.80
|
|
|
135 676 179.28
|
3 183.00
|
|
|
|
108.00
|
105.52
|
113.90
|
113.90
|
|
|
148 109 396.31
|
3 112.00
|
|
|
|
105.60
|
105.85
|
111.00
|
108.00
|
|
|
143 034 557.95
|
2 991.00
|
|
|
|
107.00
|
102.00
|
108.20
|
105.60
|
|
|
64 942 627.83
|
2 296.00
|
|
|
|
110.50
|
107.00
|
114.60
|
107.00
|
|
|
92 577 409.54
|
2 744.00
|
|
|
|
113.50
|
108.10
|
114.10
|
110.50
|
|
|
54 596 410.87
|
2 492.00
|
|
|
|
115.50
|
113.16
|
117.70
|
113.50
|
|
|
26 983 031.17
|
1 382.00
|
|
|
|
114.00
|
114.50
|
119.88
|
115.50
|
|
|
98 950 598.83
|
2 598.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2020, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2012, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
26.04.2026
|
27.04.2026 |
3.5 EGP |
|
13.04.2023
|
18.04.2023 |
2 EGP |
|
21.04.2021
|
25.04.2021 |
2.95 EGP |
|
02.05.2019
|
05.05.2019 |
4 EGP |
|
06.04.2018
|
10.04.2018 |
4.5 EGP |
|
08.05.2017
|
09.05.2017 |
3.5 EGP |
|
21.04.2016
|
24.04.2016 |
3.5 EGP |
|
23.04.2013
|
24.04.2013 |
3 EGP |
|
24.05.2012
|
27.05.2012 |
3 EGP |
|
29.04.2011
|
02.05.2011 |
2.5 EGP |
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets
